-
Company Profile
![]()
Tonix Pharmaceuticals Holding Corp – Company Profile
Tonix Pharmaceuticals Holding Corp (Tonix) a developer of pharmaceutical products to address public health challenges. The company offers pharmaceutical products and treatments for disorders of the central nervous system including fibromyalgia, post-traumatic stress disorder and episodic tension-type headache. Its products include oral formulation, smallpox vaccine, disintegrating sublingual tablets and tonmya. Tonix’s tonmya is a lead product candidate, designed as a bedtime treatment for post-traumatic stress disorder. Its disintegrating sublingual tablets contain a dose and formulation of cyclobenzaprine and is used...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1500 in Rheumatoid Arthritis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TNX-1500 in Rheumatoid Arthritis Drug Details: TNX-1500 is under development for the prevention and treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1500 in Systemic Lupus Erythematosus
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TNX-1500 in Systemic Lupus Erythematosus Drug Details: TNX-1500 is under development for the prevention and treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1500 in Kidney Transplant Rejection
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TNX-1500 in Kidney Transplant Rejection Drug Details: TNX-1500 is under development for the prevention and treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1500 in Sicca Syndrome (Sjogren)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TNX-1500 in Sicca Syndrome (Sjogren) Drug Details: TNX-1500 is under development for the prevention and treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1500 in Heart Transplant Rejection
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TNX-1500 in Heart Transplant Rejection Drug Details: TNX-1500 is under development for the prevention and treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – LR-19024 in Osteoarthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.LR-19024 in Osteoarthritis Drug Details:LR-19024 is under development for the treatment of osteoarthritis. It is administered by...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1300 in Substance (Drug) Abuse
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.TNX-1300 in Substance (Drug) AbuseDrug Details:TNX-1300 is under development for the treatment of cocaine abuse (intoxication...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Social Anxiety Disorder (SAD/Social Phobia) Drug Details: Oxytocin (TI-001) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – AMC-303 in Squamous Non-Small Cell Lung Carcinoma
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.AMC-303 in Squamous Non-Small Cell Lung Carcinoma Drug Details:AMC-303 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Migraine
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Migraine Drug Details: Oxytocin (TI-001) is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Obesity
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Obesity Drug Details: Oxytocin (TI-001) is under development for the treatment of chronic...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – (Tianeptine Oxalate + Naloxone Hydrochloride) in Major Depressive Disorder
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.(Tianeptine Oxalate + Naloxone Hydrochloride) in Major Depressive DisorderDrug Details:TNX-601 (tianeptine oxalate) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BMS-986207 in Refractory Multiple Myeloma
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BMS-986207 in Refractory Multiple Myeloma Drug Details: BMS-986207 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-102 in Alzheimer’s Disease
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-102 in Alzheimer's Disease Drug Details: TNX-102 SL (cyclobenzaprine hydrochloride, Tonmya) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – XmAb-808 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.XmAb-808 in Transitional Cell Carcinoma (Urothelial Cell Carcinoma) Drug Details:Xmab-808 is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Maveropepimut-S in Epithelial Ovarian Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Maveropepimut-S in Epithelial Ovarian Cancer Drug Details: Maveropepimut-s (DPX-Survivac) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-1900 in Binge Eating Disorder
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-1900 in Binge Eating Disorder Drug Details: Oxytocin (TI-001) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – TNX-102 in Fibromyalgia (Fibromyalgia Syndrome)
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. TNX-102 in Fibromyalgia (Fibromyalgia Syndrome) Drug Details: TNX-102 SL (cyclobenzaprine hydrochloride, Tonmya) is under development...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – INBRX-106 in Adenocarcinoma Of The Gastroesophageal Junction
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.INBRX-106 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details:INBRX-106 is under development for the treatment of...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.